Add like
Add dislike
Add to saved papers

Identifying cancer-related microRNAs based on subpathways.

IET Systems Biology 2018 December
MicroRNAs (miRNAs) are a class of small endogenous non-coding genes that play important roles in post-transcriptional regulation as well as other important biological processes. Accumulating evidence indicated that miRNAs were extensively involved in the pathology of cancer. However, determining which miRNAs are related to a specific cancer is problematic because one miRNA may target multiple genes and one gene may be targeted by multiple miRNAs. The authors proposed a new approach, named miR_SubPath, to identify cancer-associated miRNAs by three steps. The targeted genes were determined based on differentially expressed genes in significant dysfunctional subpathways. Then the candidate miRNAs were determined according to miRNA-genes associations. Finally, these candidate miRNAs were ranked based on their relations with some seed miRNAs in a functional similarity network. Results on real-world datasets showed that the proposed miR_SubPath method was more robust and could identify more cancer-related miRNAs than a prior approach, miR_Path, miR_Clust and Zhang's method.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app